TELA Bio to Announce Second Quarter 2026 Financial Results
Rhea-AI Summary
TELA Bio (NASDAQ: TELA) announced it will release its second quarter 2026 financial results on Monday, August 10, 2026. Management will host a conference call and webcast at 4:30 p.m. ET the same day to review the results and provide a corporate update.
Investors must register online to join the call, either a day in advance or at least 15 minutes before the start. A live webcast and subsequent replay will be available through the Events & Presentations page in the investor section of TELA Bio's website.
Positive
- None.
Negative
- None.
News Market Reaction – TELA
In the Jul 21 session, TELA gained 0.04%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Apr 21 | earnings date notice | Neutral | -2.6% | Scheduled second-quarter results and a 4:30 p.m. ET conference call. |
| Mar 10 | earnings date notice | Neutral | -7.3% | Scheduled fourth-quarter and full-year results with a 4:30 p.m. ET webcast. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Both prior earnings-date announcements were followed by negative 24-hour reactions, diverging from the neutral scheduling content.
Key Terms
soft-tissue reconstruction medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
MALVERN, Pa., July 20, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report second quarter 2026 financial results on Monday, August 10, 2026. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.
Second Quarter Earnings Conference Call and Webcast Details
Investors interested in listening to the conference call should register online. Participants are required to register a day in advance or at minimum 15 minutes before the start of the call. A live webcast and replay can be accessed via the Events & Presentations page of the investor section of TELA's website.
About TELA Bio, Inc.
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit www.telabio.com.
Caution Regarding Forward-Looking Statements
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Words such as "may," "might," "will," "should," "believe," "expect," "anticipate," "estimate," "continue," "predict," "forecast," "project," "plan," "intend" or similar expressions, or statements regarding intent, belief, or current expectations are forward-looking statements and reflect the current beliefs of TELA Bio's management. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors that could cause actual results and events to differ materially and adversely from those indicated by such forward-looking statements. These risks and uncertainties are described more fully in the "Risk Factors" section and elsewhere in our filings with the Securities and Exchange Commission and available at www.sec.gov, including in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements that we make in this announcement speak only as of the date of this press release, and TELA Bio assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise after the date of this press release, except as required under applicable law.
Investor Contact
Louisa Smith
ir@telabio.com
